
From risk assessment to image review, our AI breast cancer ecosystem enhances accuracy, standardizes readings, and supports informed decisions across 2D and 3D mammography, while integrating seamlessly into clinical workflows.

Our clinically proven AI detects 11 major thoracic abnormalities, supports tuberculosis screening, flags normal cases, and surfaces critical results – reducing report times, easing workloads, and empowering faster, more accurate chest X-ray decisions.
We collaborate with leading healthcare and imaging vendors to deliver seamless integration and reliable performance. Together, we enable smoother workflows and earlier cancer detection across the globe.
Stay informed with the latest research, product updates, and global partnerships driving innovation in AI-powered precision oncology.
